Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial

Autor: Masoud Solaymani-Dodaran, Pouria Basiri, Milad Moradi, Kimiya Gohari, Ali Sheidaei, Mohammadreza Ahi, Farzad Ghafoori Naeeni, Akram Ansarifar, Zahra Rahimi, Fatemeh Gholami, Ahmad Karimi Rahjerdi, Ramin Hamidi Farahani, Kosar Naderi saffar, Soheil Ghasemi, Ali Shooshtari, Mohsen Honari, Ali Mozafari, Samane Khodaverdloo, Mohsen Forooghizadeh

Publikováno v: Virology Journal, Vol 20, Iss 1, Pp 1-11 (2023)

Abstract Background We compared Fakhravac and BBIBP-Corv2 vaccines in a phase III trial. Method We conducted a multicenter, parallel-group, active-control, non-inferiority clinical trial with pragmatic considerations assessing the safety and efficacy

Externí odkaz: https://doaj.org/article/5c23619ff3214f14a8dca1f12a65f2d1

Development of Inactivated FAKHRAVAC® Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models

Autor: Soheil Ghasemi, Kosar Naderi Saffar, Firooz Ebrahimi, Pezhman Khatami, Arina Monazah, Ghorban-Ali Alizadeh, Hossein-Ali Ettehadi, Iman Rad, Shahrzad Nojehdehi, Mousa Kehtari, Fatemeh Kouhkan, Hesam Barjasteh, Sohrab Moradi, Mohammad-Hosein Ghorbani, Ali Khodaeipour, Moslem Papizadeh, Roghayeh Najafi, Ehsan Naghneh, Davood Sadeghi, Ahmad Karimi Rahjerdi

Publikováno v: Vaccines, Vol 9, Iss 11, p 1271 (2021)

The recent viral infection disease pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a global public health crisis. Iran, as one of the countries that reported over five million infected cases by Septem

Externí odkaz: https://doaj.org/article/4029ad1958be4e4ea152650fa4f5f074

Development of Inactivated FAKHRAVAC® Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models

Autor: Ahmad Karimi Rahjerdi, Davood Sadeghi, Ghorban-Ali Alizadeh, Iman Rad, Ali Khodaie, Hesam Barjasteh, Fatemeh Kouhkan, Shahrzad Nojehdehi, Soheil Ghasemi, Kosar Naderi Saffar, Pezhman Khatami, Mohammad-Hosein Ghorbani, Moslem Papizadeh, Ehsan Naghneh, Hossein-Ali Ettehadi, Roghayeh Najafi, Mousa Kehtari, Sohrab Moradi, Firooz Ebrahimi, Arina Monazah

Publikováno v: Vaccines; Volume 9; Issue 11; Pages: 1271
Vaccines, Vol 9, Iss 1271, p 1271 (2021)

The recent viral infection disease pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a global public health crisis. Iran, as one of the countries that reported over five million infected cases by Septem

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b9cfb4f8374abb01140321480f62467
https://doi.org/10.3390/vaccines9111271

Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial.

Autor: Solaymani-Dodaran, Masoud¹ (AUTHOR), Basiri, Pouria¹ (AUTHOR), Moradi, Milad² (AUTHOR), Gohari, Kimiya¹ (AUTHOR), Sheidaei, Ali¹ (AUTHOR), Ahi, Mohammadreza¹ (AUTHOR), Ghafoori Naeeni, Farzad² (AUTHOR), Ansarifar, Akram¹ (AUTHOR), Rahimi, Zahra¹ (AUTHOR), Gholami, Fatemeh¹ (AUTHOR), Karimi Rahjerdi, Ahmad³ (AUTHOR), Hamidi Farahani, Ramin⁴ (AUTHOR), Naderi saffar, Kosar² (AUTHOR), Ghasemi, Soheil³ (AUTHOR), Shooshtari, Ali³ (AUTHOR), Honari, Mohsen³ (AUTHOR), Mozafari, Ali³ (AUTHOR), Khodaverdloo, Samane³ (AUTHOR), Forooghizadeh, Mohsen⁵ (AUTHOR) mohsenforooghizadeh@gmail.com

Publikováno v: Virology Journal. 7/18/2023, Vol. 20 Issue 1, p1-11. 11p.

Tribe Eritrichieae (Boraginaceae s.str.) in West Asia: a molecular phylogenetic perspective.

Autor: Khoshsokhan Mozaffar, Maryam¹ m.khoshm@gmail.com, Kazempour Osaloo, Shahrokh² skosaloo@modares.ac.ir, Oskoueiyan, Roghayeh³ ro.osko@gmail.com, Naderi Saffar, Kosar² k_naderi_12@yahoo.com, Amirahmadi, Atefe atefeamirahmadi@yahoo.com

Publikováno v: Plant Systematics & Evolution. Jan2013, Vol. 299 Issue 1, p197-208. 12p.